OTVOXVY Trademark

Trademark Overview


On Wednesday, February 5, 2025, a trademark application was filed for OTVOXVY with the United States Patent and Trademark Office. The USPTO has given the OTVOXVY trademark a serial number of 99029205. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, August 12, 2025. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The OTVOXVY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy
otvoxvy

General Information


Serial Number99029205
Word MarkOTVOXVY
Filing DateWednesday, February 5, 2025
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, August 12, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 12, 2025

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of auditory, hematological, gastrointestinal, neuromuscular, muscular, cardiovascular, metabolic, immunological, inflammatory, oncological, ophthalmological, neurological, musculoskeletal, bone, connective tissue, dermatological, infectious, autoimmune, nephrological, hepatological, allergic, genetic, respiratory, viral, and pulmonary diseases and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of obesity; pharmaceutical preparations for immunotherapy treatment, cell therapy, and gene therapy

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 5, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Wednesday, February 5, 2025NEW APPLICATION ENTERED
Wednesday, February 5, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 30, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, June 30, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, July 7, 2025ASSIGNED TO EXAMINER
Tuesday, July 8, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 25, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 25, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 5, 2025APPLICATION FILING RECEIPT MAILED
Monday, June 30, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 6, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 12, 2025PUBLISHED FOR OPPOSITION
Tuesday, August 12, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, July 25, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED